Pain and its treatment in outpatients with metastatic cancer
- PMID: 7508092
- DOI: 10.1056/NEJM199403033300902
Pain and its treatment in outpatients with metastatic cancer
Abstract
Background and methods: Pain is often inadequately treated in patients with cancer. A total of 1308 outpatients with metastatic cancer from 54 treatment locations affiliated with the Eastern Cooperative Oncology Group rated the severity of their pain during the preceding week, as well as the degree of pain-related functional impairment and the degree of relief provided by analgesic drugs. Their physicians attributed the pain to various factors, described its treatment, and estimated the impact of pain on the patients' ability to function. We assessed the adequacy of prescribed analgesic drugs using guidelines developed by the World Health Organization, studied the factors that influenced whether analgesia was adequate, and determined the effects of inadequate analgesia on the patients' perception of pain relief and functional status.
Results: Sixty-seven percent of the patients (871 of 1308) reported that they had had pain or had taken analgesic drugs daily during the week preceding the study, and 36 percent (475 of 1308) had pain severe enough to impair their ability to function. Forty-two percent of those with pain (250 of the 597 patients for whom we had complete information) were not given adequate analgesic therapy. Patients seen at centers that treated predominantly minorities were three times more likely than those treated elsewhere to have inadequate pain management. A discrepancy between patient and physician in judging the severity of the patient's pain was predictive of inadequate pain management (odds ratio, 2.3). Other factors that predicted inadequate pain management included pain that physicians did not attribute to cancer (odds ratio, 1.9), better performance status (odds ratio, 1.8), age of 70 years or older (odds ratio, 2.4), and female sex (odds ratio, 1.5). Patients with less adequate analgesia reported less pain relief and greater pain-related impairment of function.
Conclusions: Despite published guidelines for pain management, many patients with cancer have considerable pain and receive inadequate analgesia.
Comment in
-
Treating cancer pain.N Engl J Med. 1994 Jul 21;331(3):199; author reply 201. doi: 10.1056/NEJM199407213310313. N Engl J Med. 1994. PMID: 7516494 No abstract available.
-
More on the treatment of pain.N Engl J Med. 1994 Dec 1;331(22):1528. doi: 10.1056/NEJM199412013312217. N Engl J Med. 1994. PMID: 7969315 No abstract available.
-
Treating cancer pain.N Engl J Med. 1994 Jul 21;331(3):200; author reply 201. N Engl J Med. 1994. PMID: 8008037 No abstract available.
-
Treating cancer pain.N Engl J Med. 1994 Jul 21;331(3):200; author reply 201. N Engl J Med. 1994. PMID: 8008038 No abstract available.
Similar articles
-
Pain in outpatients treated for breast cancer: prevalence, pharmacological treatment, and impact on quality of life.Cancer Nurs. 2013 May-Jun;36(3):229-35. doi: 10.1097/NCC.0b013e3182664c95. Cancer Nurs. 2013. PMID: 22964871
-
Pain and treatment of pain in minority patients with cancer. The Eastern Cooperative Oncology Group Minority Outpatient Pain Study.Ann Intern Med. 1997 Nov 1;127(9):813-6. doi: 10.7326/0003-4819-127-9-199711010-00006. Ann Intern Med. 1997. PMID: 9382402
-
Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology.JAMA. 1998 Jun 17;279(23):1877-82. doi: 10.1001/jama.279.23.1877. JAMA. 1998. PMID: 9634258
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
-
The measurement of pain from metastatic bone disease: capturing the patient's experience.Clin Cancer Res. 2006 Oct 15;12(20 Pt 2):6236s-6242s. doi: 10.1158/1078-0432.CCR-06-0988. Clin Cancer Res. 2006. PMID: 17062707 Review.
Cited by
-
Assessing cancer pain.Curr Pain Headache Rep. 2012 Aug;16(4):314-24. doi: 10.1007/s11916-012-0274-y. Curr Pain Headache Rep. 2012. PMID: 22585314 Review.
-
Significant improvements in pain after a six-week physiotherapist-led exercise and education intervention, in patients with osteoarthritis awaiting arthroplasty, in South Africa: a randomised controlled trial.BMC Musculoskelet Disord. 2016 May 27;17:236. doi: 10.1186/s12891-016-1088-6. BMC Musculoskelet Disord. 2016. PMID: 27233479 Free PMC article. Clinical Trial.
-
Heat shock protein 90 inhibitors block the antinociceptive effects of opioids in mouse chemotherapy-induced neuropathy and cancer bone pain models.Pain. 2020 Aug;161(8):1798-1807. doi: 10.1097/j.pain.0000000000001886. Epub 2020 Apr 10. Pain. 2020. PMID: 32701840 Free PMC article.
-
Access to opioid analgesics and pain relief for patients with cancer.Nat Rev Clin Oncol. 2013 Feb;10(2):108-16. doi: 10.1038/nrclinonc.2012.237. Epub 2013 Jan 15. Nat Rev Clin Oncol. 2013. PMID: 23319138 Review.
-
Long-term use of a once-a-day fentanyl citrate transdermal patch in lung cancer patients.Oncol Lett. 2015 May;9(5):2105-2108. doi: 10.3892/ol.2015.3022. Epub 2015 Mar 9. Oncol Lett. 2015. PMID: 26137021 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical